...  Top-Dollar Drug Hits the Discount Rack Filed under: drug treatment news articles Zaltrap, a joint project from Sanofi and Regeneron (Nasdaq: REGN ) , received approval from the Food and Drug Administration in August for treating patients with advanced colorectal cancer. Trials showed that Zaltrap barely extended patient lifespan by … Read more on Motley Fool  Is It Time To Look At Keryx Again? Filed under: drug treatment news articles A lot is riding on Keryx's Phase III clinical trial that is determining if Zerenex is a viable treatment for elevated phosphate levels (hyperphosphatemia) in patients with end-stage renal disease (ESRD). The study is being … In other words, the … Read more on Seeking Alpha  Alnylam: No Approved Drugs, No Promising Candidates, No Justification For … Filed under: drug treatment ...